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Introduction. In the presented retrospective study, we report on our results with partial resection of infected prosthetic
grafts after aorto-bifemoral graft placement in eight male and three female patients.
Methods. In all 11 patients clinical signs of infection were observed and bacteriological cultures were positive. Three
patients underwent immediate surgery for perforation of an aneurysm at the distal anastomosis, eight patients underwent
elective surgery. In all cases silver-coated Dacron prostheses were implanted. Assessment of outcome was based on survival,
limb salvage, persistent or recurrent infection, and prosthetic graft patency.
Results. In two cases, a partial wound dehiscence occurred which was treated with ambulant Vacuseal dressings for 16 and
21 days until secondary wound healing was achieved. In eight patients systemic markers of inflammation completed nor-
malised within nine days. Follow-up CT-scans failed to demonstrate any signs of recurrent infection or peri-graft fluid
collections. Patients were treated with specific antibiotic therapy for no more than three months. Post-operative bacterio-
logical cultures were negative in all patients. The mean follow-up was 2.5 0.5 yrs. During follow-up, none of the patients
died and there were no amputations.
Conclusion. Despite only partial resection of the infected prostheses, the reported surgical procedure offers good results.
This approach maybe particularly suitable for the treatment of elderly patients with prosthesis infections.
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The incidence of vascular prosthesis infection varies
between 0.5 and 3.5%.1e3 Infection of vascular prosthe-
ses can result in loss of the limb, functional disorder or
even death. In a study of 39 patients with infection of
vascular graft prosthesis, Zegelman reported a 30-
day-mortality of 7.6%.4 The usual therapeutic strategy
for infected aortic grafts is removal of the prosthesis
and extraanatomical bypass or in situ reconstruction
with femoral veins. In older patients this procedure
is associated with high mortality. Our strategy was
based on local infected graft excision and replacement
by a silvercoated prosthesis followed by a sartorius
flap. We present the results of this approach.
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Between January 2002 and January 2004, 11 patients
were admitted because of infection of a vascular graft
in the inguinal region. All patients had undergone sur-
gery for an infrarenal or juxtarenal abdominal aortic
aneurysm (AAA) or aortic occlusion by an aortobife-
moral graft. The mean interval between surgical inter-
vention and subsequent diagnosis of graft infection
was 3.5 0.7 years. 8 patients weremale (72 9 years),
3 patients female (67 7 years) (Table 1). Preoperative
imaging included computer or magnetic resonance to-
mography. Bacteriological cultures were positive in all
patients (Table 2). Three patients underwent immedi-
ate surgery because of perforation of an infected aneu-
rysm of the distal anastomosis, all other patients
underwent elective surgery. During the surgical proce-
dure the infected limb of the prosthesis was resected
and replaced by a silvercoated Dacron prosthesis.
Thereafter, a sartorius flap was constructed to coverrved.
611Prosthesis Infection in Severely Ill Patientsthe graft (Figs. 1 and 2). Cultures from the wounds and
laboratory parameters of infection were assessed
every 72 h. Patients were treated with systemic anti-
biotics related to sensitivity. Two wound drains were
placed in situ for at least 10 days. Postoperative CT
was performed to assess paraaortic infection. All pa-
tients were treated with antibiotic drug therapy for
not longer than three months. The mean follow-up
was 2.5 0.5 years.
Results
The pertinent risk factors in our study population in-
cluded coronary artery disease, hypertension, type II
diabetes mellitus, hyperlipidemia, chronic obstructive
pulmonary disease, and renal failure. All mycotic an-
eurysms of the anastomoses were treated as emergen-
cies. In all patients, the entire prosthetic limb was
excised up to the inguinal ligament and in situ recon-
struction with a silvercoated prosthesis, debridement
of surrounding tissues and pedicled sartorius flap
was performed (Figs. 1e3). The mean duration of sur-
gery was 186 43 minutes. ICU stay was 1.3 0.6
days, mean hospitalization time was 12 4 days. In
Table 1. Baseline characteristics of the study population
Male Female
n¼ 8 n¼ 3
Age (mean SD) 72 9 67 7
Concomitant Diseases
CHD 4 (36.3%) 1 (9%)
Hypertonia 5 (45.4%) 2 (18.1%)
Hyperlipidemia 2 (18.1%) 2 (18.1%)
Pulmanary obstructive disease 5 (45.4%) 1 (9%)
Renal failure 3 (27.2%) 2 (18.1%)
Diabetes mellitus typ II 5 (45.4%) 2 (18.1%)
Several medication 8 (72.7%) 3 (27.2%)
Continous variables are presented as mean standard deviation.
Categorical variables are presented as an absolute percentage.
Abbreviations: CHD: Coronary heart disease.
Table 2. Bactriological findings
Patient Gender Age Bacteriological finding
Patient 1 M 75 Streptococcus viridans
Patient 2 F 73 Coagulase-neg. staphyl.
Patient 3 M 76 Coagulase-neg. staphyl.
Patient 4 M 56 Staphylococcus aureus
Patient 5 F 59 Staphylococcus aureus
Patient 6 M 72 Streptococcus faecalis
Patient 7 F 69 Staphylococcus aureus
Patient 8 M 67 Staphylococcus aureus
Patient 9 M 71 Streptococcus viridans
Patient 10 M 85 Staphylococcus aureus
Patient 11 M 79 Coagulase-neg. staphyl.
Abbreviations: M: male, F: female.two patients, a partial wound dehiscence was
observed. In both cases, treatment with a Vacuseal
dressing was implemented. After 16 and 21 days of
ambulant treatment, secondary wound healing was
Fig. 2. Intraoperative findings: debridement of surrounding
tissues, replacement by a silver-coated Dacron prosthesis
and pedicled sartorius flap.
Fig. 1. Preoperative findings. Infection of a vascular graft in
the inguinal region with percutanous fistula.Eur J Vasc Endovasc Surg Vol 33, May 2007
612 M. Mirzaie et al.achieved. In eight patients we observed systemic
markers of infection before surgery. Within nine
days after surgery, all parameters regained normal
values. We observed no inhospital deaths and all pa-
tients survived the follow-up of two years. Postopera-
tive CT scans revealed no signs of recurrent infection
or perigraft fluid collections. Patients received anti-
biotic therapy for no more than three months. Post-
operative bacteriological cultures were negative in
all patients.
Discussion
Very diverse approaches to the treatment of vascular
prosthesis infection exist. Up to now, no optimal
strategy for the treatment of prosthesis infection of
aortic-bifemoral prostheses that reliably ensures
satisfactorily results has been reported. Traditional
management of infected prosthetic grafts consists of
complete removal of the infected graft prosthesis
and revascularisation by extraanatomic bypass gra-
fting. This approach has several disadvantages
compared with in situ replacement.5e7 Moreover,
depending on the area affected by microbiological col-
onisation, the extraanatomical reconstruction with an
allograft may entail disadvantages resulting from
lower blood flow, poorer patency rate, gluteal ische-
mia, higher mortality and increased reinfection.8e10
In situ aortic replacement is not always possible par-
ticulary when the stump is short.11 Several working
groups have presented favorable results with in situ
reconstruction with deep leg veins, homografts
Fig. 3. Postoperative findings: view of the inguinal region 12
days after operation.Eur J Vasc Endovasc Surg Vol 33, May 2007or rifampicin-soaked Dacron prostheses.6,12,13 The
corresponding trauma accompanying resection of
the deep leg veins, the problem of availability and
later degeneration of homografts and a relatively
short residence time of antibiotics in the prosthesis
constitute the drawbacks of these approaches.12,13
The collagen silvercoated polyester graft is part of
a new protheses generation for the treatment of pros-
thesis infection.4,14 In the reported 11 cases an excision
of the infected prosthesis and replacement with extra-
anatomical bypasses were not recommendable be-
cause of the physical condition of the elderly and
severely ill patients. In all cases, resection of the
infected limb of the prosthesis up to the inguinal
ligament and in situ revascularisation with a silver-
coated prosthesis was successfully performed. The
procedure was completed by wound closure using
a sartorius myo flap. During preoperative and post-
operative follow-up, no major complications were ob-
served and local infections were relieved in all cases.
Postoperative CT scans demonstrated no pathological
signs of infection. Additionally, all markers of sys-
temic inflammation returned to normal after surgery.
Within a 2.5-year follow-up no deaths occurred.
The need to remove all infected prosthesis material
in late graft failure remains a controversial issue.5e7
Despite Bandyk et al. having reported a 41% rate of
re-infection after incomplete removal of the infected
prosthesis,5 we did not observe any reinfection in
our patients within a follow-up period of 2.5 years.
Although prosthesis material was only partially re-
sected, the surgical procedure described here offers
an alternative approach in the treatment of prosthesis
infections in elder and comorbid patients that prom-
ises to increase their quality of life. We would like to
emphasize that the reported procedure should only
be used in a defined group of patients and should
not be used routinely in all patients. If the indication
for this procedure is carefully considered, it offers
beneficial results for the treatment of local prostheses
infections.
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